(Q38215315)

31 August 2017

Mitochondrial dysfunction in central nervous system white matter disorders (English)

1 reference

31 August 2017

0 references

Anna Ardissone

4

0 references

Montserrat Ruiz

Montse Ruiz

5

0 references

Aurora Pujol

Aurora Pujol

8

0 references

Enrico Bertini

Enrico Bertini

2

0 references

Graziella Uziel

7

Graziella Uziel

1 reference

31 August 2017

6

Isidre Ferrer

1 reference

31 August 2017

1

Laia Morató

1 reference

31 August 2017

Daniela Verrigni

3

1 reference

31 August 2017

28 May 2014

1 reference

31 August 2017

1 reference

31 August 2017

62

1 reference

31 August 2017

11

1 reference

31 August 2017

1878-1894

1 reference

Pharmacological approaches to restore mitochondrial function

31 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondria take center stage in aging and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Clinical and molecular findings in children with complex I deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial changes within axons in multiple sclerosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Abnormalities in uridine homeostatic regulation and pyrimidine nucleotide metabolism as a consequence of the deletion of the uridine phosphorylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Idebenone treatment in Leber's hereditary optic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondria as a central sensor for axonal degenerative stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial DNA disease: new options for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The clinical maze of mitochondrial neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

General aspects and neuropathology of X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Adeno-associated virus-mediated gene transfer of the heart/muscle adenine nucleotide translocator (ANT) in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial encephalomyopathy due to a novel mutation in ACAD9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Altered postnatal development of cortico-hippocampal neuronal electric activity in mice deficient for the mitochondrial aspartate-glutamate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Biochemistry of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Novel mutations in the NDUFS1 gene cause low residual activities in human complex I deficiencies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial gene therapy improves respiration, biogenesis, and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The involvement of mitochondria in the pathogenesis of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Accumulation of oxidative stress around the stroke-like lesions of MELAS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

NUBPL mutations in patients with complex I deficiency and a distinct MRI pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Progress and prospects: gene therapy for mitochondrial DNA disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Pathology and disease mechanisms in different stages of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mechanisms of white matter damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The molecular basis of neurodegeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Progressive multiple sclerosis: pathology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Oxidative stress regulates the ubiquitin-proteasome system and immunoproteasome functioning in a mouse model of X-adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mouse mtDNA mutant model of Leber hereditary optic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Isolated complex I deficiency in children: clinical, biochemical and genetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Molecules and roles of mitochondrial calcium signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Is multiple sclerosis a mitochondrial disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

EPI-743 reverses the progression of the pediatric mitochondrial disease--genetically defined Leigh Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The link between excitotoxic oligodendroglial death and demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Excitotoxicity: bridge to various triggers in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Astrocytes and disease: a neurodevelopmental perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

How mitochondria produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Progressive cavitating leukoencephalopathy: a novel childhood disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial reactive oxygen species drive proinflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Co-enzyme Q10 and idebenone use in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

New treatments for mitochondrial disease-no time to drop our standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Inhibition of mitochondrial function induces an integrated stress response in oligodendroglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

The powerhouse takes control of the cell: is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Multifunctional role of astrocytes as gatekeepers of neuronal energy supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial gene replacement in primate offspring and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial DNA mutations affect calcium handling in differentiated neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Increased expression and function of glutamate transporters in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Inhibition of mitochondrial Na+-Ca2+ exchange restores agonist-induced ATP production and Ca2+ handling in human complex I deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75/mortalin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial energetics and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Axon degeneration: Molecular mechanisms of a self-destruction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

RETRACTED: Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

AGC1 deficiency associated with global cerebral hypomyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial Ca2+ homeostasis in human NADH:ubiquinone oxidoreductase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Mitochondrial syndromes with leukoencephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

A role for mitochondria in NLRP3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

64Cu-labeled lissamine rhodamine B: a promising PET radiotracer targeting tumor mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

Somatic Progenitor Cell Vulnerability to Mitochondrial DNA Mutagenesis Underlies Progeroid Phenotypes in Polg Mutator Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Myelination and the trophic support of long axons

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Leukoencephalopathy with vanishing white matter caused by compound heterozygous mutations in mitochondrial complex I NDUFS1 subunit

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Deficiency of the mitochondrial transporter of aspartate/glutamate aralar/AGC1 causes hypomyelination and neuronal defects unrelated to myelin deficits in mouse brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Caspase-Dependent and Caspase-Independent Oligodendrocyte Death Mediated by AMPA and Kainate Receptors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.22670

7 January 2021

Identifiers

DOI

10.1002/GLIA.22670

1 reference

31 August 2017

1 reference

PubMed ID

24865954